Nav1.5 Ser571 Phosphorylation in Cardiac Aging

2026-09-02

The 2024 reference study identifies Nav1.5 phosphorylation at Ser571 as a mechanistic link between increased late sodium current, delayed ventricular repolarization, and impaired diastolic relaxation. By combining age-stratified wild-type mice with phosphomimetic and phosphoablated models, the work shows that late sodium current remodeling can anticipate or attenuate features of the aging myopathy, providing a framework for targeted cardiac electrophysiology studies.

Leupeptin Hemisulfate Salt: Practical Assays

2026-09-02

Leupeptin, Microbial supports controlled protease activity regulation, protein degradation studies, autophagy experiments, and model-specific viral replication inhibition. This workflow-focused guide combines fresh-solution handling, competitive enzyme assays, cell-based controls, and the binding-validation logic of a modern TET2 protocol.

CDK9 inhibitor A3294: Protocol and QC Guide

2026-09-01

CDK9 inhibitor A3294 is a selective serine/threonine kinase inhibitor for testing CDK9-dependent transcription elongation and exploratory HIV-1 propagation inhibition. It is suited to controlled biochemical and cellular workflows, but not to broad CDK inhibition, therapeutic conclusions, or long-term storage of prepared solutions.

Tunicamycin as a Context-Aware ER Stress Probe

2026-09-01

Tunicamycin is a powerful N-glycosylation inhibitor, but its experimental meaning depends on cell type, exposure, and rescue design. This guide connects glycosylation blockade to macrophage inflammation and splenic T-cell dysfunction while translating the evidence into better assay decisions.

Praeruptorin A: Applied Research Workflows

2026-08-31

Praeruptorin A is an angular pyranocoumarin compound suited to integrated ferroptosis, inflammation, barrier-function, cardiomyopathy, and metastasis workflows. This practical guide connects concentration selection, orthogonal readouts, formulation control, and troubleshooting for more reproducible preclinical experiments.

Perphenazine: From D2 Antagonism to Host Defense

2026-08-30

Perphenazine is a dopamine D2 receptor antagonist whose value extends from neuropharmacology into mechanistic host-defense research. This article develops an assay-centered framework connecting receptor pharmacology, mitochondrial stress, ROS, autophagy, and intracellular antibacterial activity.

OLIG2 mRNA for Rapid hiPSC Oligodendrocyte Differentiation

2026-08-29

Phenothiazines Boost Macrophage Antibacterial Defense

2026-08-29

A 2025 Frontiers in Immunology study shows that phenothiazines strengthen macrophage control of intracellular bacteria by coordinating reactive oxygen species accumulation, lysosomal activity, and autophagy. The work positions perphenazine as a host-directed antibacterial lead while emphasizing that its immune mechanism should not be assumed to arise from dopamine receptor blockade.

ABT-888 (Veliparib) Workflow for DNA Repair Studies

2026-08-28

ABT-888 (Veliparib) provides a practical way to model PARP1/2-dependent DNA repair inhibition and test chemotherapy or radiation sensitization. This workflow emphasizes formulation control, genotype-aware assay design, and the context-specific limits revealed by recent acute leukemia screening data.

Chicken GSDME and RNA Virus-Induced Pyroptosis

2026-08-28

Chen et al. identify chicken Gasdermin E as a central pore-forming effector of RNA virus-induced pyroptosis, resolving a major question created by the absence of GSDMD in chickens. Their DF-1 cell experiments connect MDA5-dependent sensing with caspase-3/7 activation, cleavage of chGSDME at 270DAVD273, and reduced pyroptosis and viral release after chGSDME depletion.

Human iPSC Sensory Neurons Model HSV-1 Latency

2026-08-27

Oh et al. developed a scalable human induced pluripotent stem cell-derived sensory neuron system that reproduces major molecular features of HSV-1 latency and supports pharmacological reactivation. The model provides a human neuronal platform for studying viral chromatin control, neuron-intrinsic latency mechanisms, and candidate interventions.

Affordable GRO-seq Profiling in Bread Wheat

2026-08-27

This STAR Protocols study introduces an rRNA-depletion step that makes Global Run-On sequencing more efficient for profiling nascent transcription in allohexaploid bread wheat. The workflow improved the proportion of valid sequencing data by 20-fold in the authors’ application, providing a practical route for studying enhancer transcription in complex genomes.

iPSC Prescreening for Ultrarare Disease Trials

2026-08-26

Sequiera et al. developed a patient-specific iPSC platform to evaluate treatment candidates for an ultrarare Leigh-like syndrome caused by previously uncharacterized ECHS1 variants. The study shows how genotype-matched cellular models may reduce trial-and-error decisions by connecting drug screening with longitudinal clinical and metabolic assessment.

Sabutoclax: Pan-Bcl-2 Inhibitor Evidence

2026-08-26

Sabutoclax is a pan-Bcl-2 inhibitor and apogossypolone derivative that targets Bcl-2, Bcl-xL, Mcl-1, and Bfl-1. Reported biochemical, cellular, and animal findings support its use as a preclinical tool for apoptosis induction in cancer cells, while assay conditions and clinical translation remain important limitations.

Neuromedin S (rat): GPCR Assay Guide

2026-08-25

Neuromedin S (rat), SKU B5466, provides a defined peptide agonist for controlled neuromedin U receptor signaling studies, including GPCR/G protein signaling workflows relevant to energy homeostasis regulation and stress response research. It should be used as a research reagent in validated laboratory assays, not as a diagnostic, therapeutic, or medical product.